Adaptive oncology Phase I trial design of drug combinations with drug-drug interaction modeling

DOI10.4310/SII.2018.V11.N1.A10OpenAlexW2750000091MaRDI QIDQ1782097

Ming Tan, Hong-Bin Fang, Anindya Roy, Yang Yang

Publication date: 18 September 2018

Published in: Statistics and Its Interface (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.4310/sii.2018.v11.n1.a10

zbMATH Keywords

objective functiondrug combinationdose findingadaptive Bayesian designBliss independenceinteraction index functionmaximum tolerated dose (MTD)maximum tolerated region

Mathematics Subject Classification ID

Statistics (62-XX)

This page was built for publication: Adaptive oncology Phase I trial design of drug combinations with drug-drug interaction modeling